ArticleHeliyon2020

Kampo medicines, Rokumigan, Hachimijiogan, and Goshajinkigan, significantly inhibit glucagon-induced CREB activation.

Megumi Funakoshi-Tago et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.